A transgenic zebrafish model of hepatocyte function in human Z α1-antitrypsin deficiency

被引:2
|
作者
Yip, Evelyn [1 ]
Giousoh, Aminah [1 ]
Fung, Connie [1 ]
Wilding, Brendan [1 ]
Prakash, Monica D. [1 ]
Williams, Caitlin [2 ]
Verkade, Heather [3 ]
Bryson-Richardson, Robert J. [2 ]
Bird, Phillip I. [1 ]
机构
[1] Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Melbourne, Vic 3800, Australia
[2] Monash Univ, Sch Biol Sci, Melbourne, Vic 3800, Australia
[3] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3052, Australia
基金
英国医学研究理事会;
关键词
alpha(1)-antitrypsin deficiency; Danio rerio; liver; serpin; SERPINA1; LIVER-DISEASE; MOUSE MODEL; ALPHA(1)-ANTITRYPSIN DEFICIENCY; GENE-EXPRESSION; ACCUMULATION; TRANSPOSON; HEPATITIS; MECHANISM; PATHOLOGY; CIRRHOSIS;
D O I
10.1515/hsz-2018-0391
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In human alpha 1-antitrypsin deficiency, homozygous carriers of the Z (E324K) mutation in the gene SERPINA1 have insufficient circulating alpha 1-antitrypsin and are predisposed to emphysema. Misfolding and accumulation of the mutant protein in hepatocytes also causes endoplasmic reticulum stress and underpins long-term liver damage. Here, we describe transgenic zebrafish (Danio rerio) expressing the wildtype or the Z mutant form of human alpha 1-antitrypsin in hepatocytes. As observed in afflicted humans, and in rodent models, about 80% less alpha 1-antitrypsin is evident in the circulation of zebrafish expressing the Z mutant. Although these zebrafish also show signs of liver stress, they do not accumulate alpha 1-antitrypsin in hepatocytes. This new zebrafish model will provide useful insights into understanding and treatment of alpha 1-antitrypsin deficiency.
引用
收藏
页码:1603 / 1616
页数:14
相关论文
共 50 条
  • [41] The selective advantage of α1-antitrypsin deficiency
    Lomas, DA
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2006, 173 (10) : 1072 - 1077
  • [42] Augmentation therapy in α1-antitrypsin deficiency
    Burdon, JGW
    Brenton, S
    Ayad, M
    Knight, K
    CHEST, 2001, 120 (02) : 687 - 687
  • [43] α1-antitrypsin deficiency and Pi typing
    Barlow, Ian
    Sewell, W. A. Carrock
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 122 (03) : 658 - 658
  • [44] Augmentation therapy for α1-antitrypsin deficiency
    Juvelekian, GS
    Stoller, JK
    DRUGS, 2004, 64 (16) : 1743 - 1756
  • [45] Pneumothorax Associated with α1-Antitrypsin Deficiency
    Kanazawa, Shigenori
    Kinoshita, Yoshimi
    Nakagawa, Yuki
    Akai, Miku
    Ookura, Mari
    Uemura, Shinobu
    Yamaguchi, Kazuyuki
    Nomura, Shosaku
    INTERNAL MEDICINE, 2009, 48 (05) : 387 - 388
  • [46] Author Correction: α1-Antitrypsin deficiency
    Catherine M. Greene
    Stefan J. Marciniak
    Jeffrey Teckman
    Ilaria Ferrarotti
    Mark L. Brantly
    David A. Lomas
    James K. Stoller
    Noel G. McElvaney
    Nature Reviews Disease Primers, 4 (1)
  • [47] Aortic degeneration in α1-antitrypsin deficiency
    Blair, HC
    Zorn, G
    Young, R
    McGiffin, DC
    HISTOPATHOLOGY, 2000, 37 (04) : 377 - 378
  • [48] Myeloma complicated by α1-antitrypsin deficiency
    Heys, AD
    Lapsley, M
    Day, JB
    Williams, CD
    ANNALS OF CLINICAL BIOCHEMISTRY, 1998, 35 : 149 - 151
  • [49] Analyses of hepatocellular proliferation in a mouse model of α-1-antitrypsin deficiency
    Rudnick, DA
    Liao, YJ
    An, JK
    Muglia, LJ
    Perlmutter, DH
    Teckman, JH
    HEPATOLOGY, 2004, 39 (04) : 1048 - 1055
  • [50] Alpha 1-Antitrypsin Deficiency And Sarcoidosis
    Lonial, K.
    Patel, P.
    Afshar, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189